Prevention of cardiovascular disease in adult recipients of kidney transplants von Jardine, Alan G, Prof, Gaston, Robert S, Prof, Fellstrom, Bengt C, Prof, Holdaas, Hallvard, MD

Volltext

Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients von Dahle, Dag Olav, Grotmol, Tom, Leivestad, Torbjørn, Hartmann, Anders, Midtvedt, Karsten, Reisæter, Anna V, Mjøen, Geir, Pihlstrøm, Hege K, Næss, Hege, Holdaas, Hallvard

Volltext

High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation von Egeland, Erlend Johannessen, Robertsen, Ida, Hermann, Monica, Midtvedt, Karsten, Størset, Elisabet, Gustavsen, Marte Theie, Reisæter, Anna Varberg, Klaasen, Rolf, Bergan, Stein, Holdaas, Hallvard, Hartmann, Anders, Åsberg, Anders

Volltext

Effects of Lowering LDL Cholesterol on Progression of Kidney Disease von HAYNES, Richard, LEWIS, David, LEVIN, Adeera, WHEELER, David C, WALKER, Rob, HERRINGTON, William G, BAIGENT, Colin, LANDRAY, Martin J, EMBERSON, Jonathan, REITH, Christina, AGODOA, Lawrence, CASS, Alan, CRAIG, Jonathan C, DE ZEEUW, Dick, FELDT-RASMUSSEN, Bo, FELLSTRÖM, Bengt

Volltext

Conversion of Long-Term Kidney Transplant Recipients From Calcineurin Inhibitor Therapy to Everolimus: A Randomized, Multicenter, 24-Month Study von HOLDAAS, Hallvard, ROSTAING, Lionel, ULBRICHT, Bettina, KARPOV, Alexander, O'CONNELL, Philip J, SERON, Daniel, COLE, Edward, CHAPMAN, Jeremy, FELLSTRØM, Bengt, STROM, Erik H, JARDINE, Alan, MIDTVEDT, Karsten, MACHEIN, Uwe

Volltext

Rosuvastatin in Diabetic Hemodialysis Patients von HOLDAAS, Hallvard, HOLME, Ingar, SCHMIEDER, Roland E, JARDINE, Alan G, ZANNAD, Faiez, NORBY, Gudrun E, FELLSTRÖM, Bengt C

Volltext

Atorvastatin and Low-Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus Patients on Hemodialysis von März, Winfried, Genser, Bernd, Drechsler, Christiane, Krane, Vera, Grammer, Tanja B, Ritz, Eberhard, Stojakovic, Tatjana, Scharnagl, Hubert, Winkler, Karl, Holme, Ingar, Holdaas, Hallvard, Wanner, Christoph

Volltext

Early Versus Late Acute Antibody-Mediated Rejection in Renal Transplant Recipients von Dörje, Christina, Midtvedt, Karsten, Holdaas, Hallvard, Naper, Christian, Strøm, Erik H, Øyen, Ole, Leivestad, Torbjørn, Aronsen, Tommy, Jenssen, Trond, Flaa-Johnsen, Linda, Lindahl, Jørn Petter, Hartmann, Anders, Reisæter, Anna Varberg

Volltext

Morbidity and Mortality in 1022 Consecutive Living Donor Nephrectomies: Benefits of a Living Donor Registry von MJØEN, Geir, ØYEN, Ole, HOLDAAS, Hallvard, MIDTVEDT, Karsten, LINE, Pal-Dag

Volltext

Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients von Pihlstrom, Hege Kampen, Ueland, Thor, Michelsen, Annika E., Aukrust, Pal, Gatti, Franscesca, Hammarstrom, Clara, Kasprzycka, Monika, Wang, Junbai, Haraldsen, Guttorm, Mjoen, Geir, Dahle, Dag Olav, Midtvedt, Karsten, Eide, Ivar Anders, Hartmann, Anders, Holdaas, Hallvard

Volltext

Inflammation in Renal Transplantation von Abedini, Sadollah, Holme, Ingar, März, Winfried, Weihrauch, Gisela, Fellström, Bengt, Jardine, Alan, Cole, Edward, Maes, Bart, Neumayer, Hans-Hellmut, Grønhagen-Riska, Carola, Ambühl, Patrice, Holdaas, Hallvard

Volltext

Belatacept: Where the BENEFITS Outweigh the Risk von Holdaas, Hallvard, MD, PhD, Mjøen, Geir, MD, PhD, Jardine, Alan G., BSc, MD, FRCP

Volltext

Early introduction of oral paricalcitol in renal transplant recipients. An open‐label randomized study von Pihlstrøm, Hege Kampen, Gatti, Franscesca, Hammarström, Clara, Eide, Ivar Anders, Kasprzycka, Monika, Wang, Junbai, Haraldsen, Guttorm, Svensson, My Hanna Sofia, Midtvedt, Karsten, Mjøen, Geir, Dahle, Dag Olav, Hartmann, Anders, Holdaas, Hallvard

Volltext

Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation von Mjörnstedt, Lars, Schwartz Sørensen, Søren, zur Mühlen, Bengt, Jespersen, Bente, Hansen, Jesper M., Bistrup, Claus, Andersson, Helene, Gustafsson, Bengt, Solbu, Dag, Holdaas, Hallvard

Volltext

Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients - a three-yr serial echocardiographic substudy of the randomized contro... von Murbraech, Klaus, Massey, Richard, Undset, Liv H., Midtvedt, Karsten, Holdaas, Hallvard, Aakhus, Svend

Volltext

Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score von Ussif, Amin, Pihlstrøm, Hege, Pasch, Andreas, Holdaas, Hallvard, Hartmann, Anders, Smerud, Knut, Åsberg, Anders

Volltext

Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation von Gude, Einar, MD, Gullestad, Lars, MD, PhD, Arora, Satish, MD, Simonsen, Svein, MD, PhD, Hoel, Ina, RN, Hartmann, Anders, MD, PhD, Holdaas, Hallvard, MD, PhD, Fiane, Arnt E., MD, PhD, Geiran, Odd R., MD, PhD, Andreassen, Arne K., MD, PhD

Volltext

Long term risk of mortality after living kidney donation von Mjøen, Geir, Holdaas, Hallvard

Volltext

Model Comparisons of Competing Risk and Recurrent Events for Graft Failure in Renal Transplant Recipients von Holme, Ingar, Fellström, Bengt C, Jardine, Alan G, Hartmann, Anders, Holdaas, Hallvard

Volltext

Experience From an Active Preemptive Kidney Transplantation Program―809 Cases Revisited von WITCZAK, Bartlomiej J, LEIVESTAD, Torbjørn, DAG LINE, Pal, HOLDAAS, Hallvard, REISAETER, Anna V, JENSSEN, Trond G, MIDTVEDT, Karsten, BITTER, Jan, HARTMANN, Anders

Volltext